Nishida Yayoi, Takahashi Yasuo, Tezuka Kotoe, Yamazaki Keiko, Yada Yoichi, Nakayama Tomohiro, Asai Satoshi
Division of Genomic Epidemiology and Clinical Trials, Clinical Trials Research Center.
Division of Pharmacology, Department of Biomedical Sciences.
Int J Chron Obstruct Pulmon Dis. 2017 Aug 8;12:2363-2371. doi: 10.2147/COPD.S138103. eCollection 2017.
Multiple comorbidity is common and increases the complexity of the presentation of patients with COPD. This study was a comprehensive analysis of the relationship between a medical history of 22 disease categories and the presence of airflow limitation (AL) without any history of asthma or bronchiectasis, compatible with COPD.
A total of 11,898 Japanese patients aged ≥40 years, who underwent spirometry tests, comprising patients with AL (n=2,309) or without AL (n=9,589), were evaluated. Generalized estimating equations were used to assess the relationship between the presence of AL and each disease. The model was adjusted for age, sex, body mass index (BMI) and pack-years of smoking.
In multivariate analysis, female sex (odds ratio [OR]: 0.59; 95% confidence interval [CI]: 0.52-0.67), age (OR for 10-year age increase: 1.99; CI: 1.90-2.09), BMI (OR for 1 kg/m increase: 0.96; CI: 0.95-0.98) and smoking history (<15 vs 15-24, 25-49 and ≥50 pack-years; OR: 1.78, 2.6 and 3.69, respectively; CI: 1.46-2.17, 2.24-3.0 and 3.15-4.33, respectively) were significantly associated with the presence of AL. In addition, a history of tuberculosis (OR: 1.72; CI: 1.39-2.11), primary lung cancer (OR: 1.50; CI: 1.28-1.77), myocardial infarction (OR: 1.22; CI: 1.01-1.48), heart failure (OR: 1.53; CI: 1.29-1.81), arrhythmia (OR: 1.19; CI: 1.03-1.38) or heart valve disorder (OR: 1.33; CI: 1.14-1.56) was significantly associated with the presence of AL, after adjustment.
This study suggests that a history of heart disease leading to abnormal cardiac function may be associated with AL and that the presence of certain types of heart disease provides a rationale to assess lung status and look for respiratory impairment, including COPD.
多种合并症很常见,会增加慢性阻塞性肺疾病(COPD)患者临床表现的复杂性。本研究全面分析了22种疾病类别的病史与气流受限(AL)的存在之间的关系,这些患者无哮喘或支气管扩张病史,符合COPD。
对总共11898名年龄≥40岁且接受了肺活量测定的日本患者进行了评估,其中包括有AL的患者(n = 2309)或无AL的患者(n = 9589)。使用广义估计方程来评估AL的存在与每种疾病之间的关系。该模型针对年龄、性别、体重指数(BMI)和吸烟包年数进行了调整。
在多变量分析中,女性(优势比[OR]:0.59;95%置信区间[CI]:0.52 - 0.67)、年龄(每增加10岁的OR:1.99;CI:1.90 - 2.09)、BMI(每增加1 kg/m²的OR:0.96;CI:0.95 - 0.98)和吸烟史(<15对比15 - 24、25 - 49和≥50包年;OR分别为:1.78、2.6和3.69;CI分别为:1.46 - 2.17、2.24 - 3.0和3.15 - 4.33)与AL的存在显著相关。此外,在调整后,结核病病史(OR:1.72;CI:1.39 - 2.11)、原发性肺癌(OR:1.50;CI:1.28 - 1.77)、心肌梗死(OR:1.22;CI:1.01 - 1.48)、心力衰竭(OR:1.53;CI:1.29 - 1.81)、心律失常(OR:1.19;CI:1.03 - 1.38)或心脏瓣膜疾病(OR:1.33;CI:1.14 - 1.56)与AL的存在显著相关。
本研究表明,导致心功能异常的心脏病史可能与AL相关,并且某些类型心脏病的存在为评估肺部状况和寻找包括COPD在内的呼吸功能损害提供了依据。